One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome

Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome

(2010) Domenico Giordano et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Uncoupling Between Insulin and Release of a d-Chiro-Inositol–Containing Inositolphosphoglycan Mediator of Insulin Action in Obese Women With Polycystic Ovary Syndrome

(2010) Jean-Patrice Baillargeon et al.   Metabolic Syndrome and Related Disorders

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial

(2009) A. Fontbonne et al.   DIABETES & METABOLISM

Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome

(2008) A. K. Gupta et al.   DIABETES OBESITY & METABOLISM

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

(2008) Alessandro D. Genazzani et al.   GYNECOLOGICAL ENDOCRINOLOGY

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review

(2007) Pierre Amarenco et al.   ATHEROSCLEROSIS